A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma

Author: Bedikian Agop   Papadopoulos Nicholas   Kim Kevin   Hwu Wen-Jen   Homsi Jade   Glass Michelle   Cain Suzanne   Rudewicz Patrick   Vernillet Laurent   Hwu Patrick  

Publisher: Informa Healthcare

ISSN: 0735-7907

Source: Cancer Investigation, Vol.27, Iss.7, 2009-08, pp. : 756-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content